DAPAGLIFLOZIN: SELECTIVE SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITOR IN TYPE 2 DIABETES. (2011). International Research Journal of Pharmacy, 2(11), 125-126. https://irjponline.org/index.php/irjp/article/view/2988